Odiparcil QT Definitive Study

Status:
Terminated

Trial end date:
1969-12-31

Target enrollment:

Participant gender:

This study is being completed to demonstrate the lack of effect of repeat dosing with Odiparcil on the QTc interval.

Phase 1

GlaxoSmithKline